These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7694127)

  • 41. Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma.
    Stoika RS; Yakymovych IA; Kashchak NI; Boyko MM; Korynevska AV; Klyuchyvska OY; Shafranska GI; Yakymovych MY; Zhylchuk VY; Kudryavets YY; Vorontsova AL
    Exp Oncol; 2008 Mar; 30(1):35-41. PubMed ID: 18438339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular oncogenes in human teratocarcinoma cell lines.
    Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
    Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Oncogene expression in adriamycin and platinum resistant cell lines].
    Liu YB
    Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):552-4, 576. PubMed ID: 7906188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment.
    Caney C; Bulmer JT; Singh G; Lukka H; Rainbow AJ
    Int J Radiat Biol; 1999 Aug; 75(8):963-72. PubMed ID: 10465362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in effects of oncogenes on resistance of gamma rays, ultraviolet light, and heat shock.
    Suzuki K; Watanabe M; Miyoshi J
    Radiat Res; 1992 Feb; 129(2):157-62. PubMed ID: 1734445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of multiple oncogenes in human esophageal carcinomas.
    Wong FH; Hu CP; Chiu JH; Huang BS; Chang JP; Lin PJ; Chien KY; Chang C
    Cancer Invest; 1994; 12(2):121-31. PubMed ID: 8131089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras.
    Fan J; Banerjee D; Stambrook PJ; Bertino JR
    Biochem Pharmacol; 1997 Apr; 53(8):1203-9. PubMed ID: 9175726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.
    Kashani-Sabet M; Wang W; Scanlon KJ
    J Biol Chem; 1990 Jul; 265(19):11285-8. PubMed ID: 2113532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes].
    Niimi S; Yokoyama S; Terashima Y; Saijo N
    Hum Cell; 1991 Mar; 4(1):33-7. PubMed ID: 1888702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin.
    Osmak M; Eljuga D
    Res Exp Med (Berl); 1993; 193(6):389-96. PubMed ID: 8122044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to 195mPt-radiolabeled cis-diaminedichloroplatinum (II) of SHOK cells transfected with various oncogenes.
    Kinashi Y; Akaboshi M; Masunaga S; Ono K; Watanabe M
    Radiat Med; 1998; 16(4):233-7. PubMed ID: 9814416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy].
    Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C
    Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Search for oncogene mutations in X-ray-transformed mouse 10T1/2 cells by denaturing gradient gel electrophoresis blotting.
    Krolewski B; Little JB
    Int J Radiat Biol; 1994 Feb; 65(2):147-56. PubMed ID: 7907112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
    Sugimoto KJ; Kawamata N; Sakajiri S; Oshimi K
    Jpn J Cancer Res; 2002 Nov; 93(11):1270-7. PubMed ID: 12460470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA; Xu X; Stambrook PJ
    Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of myc and ras oncogenes in two newly established neuroblastoma cell lines.
    Csaikl F; Müllauer L; Csaikl U; Vetterlein M
    J Cancer Res Clin Oncol; 1989; 115(3):242-6. PubMed ID: 2666422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.